4 completed, 1 terminated. 5 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 4, Terminated 1 |
| Phase 3 | 3 | Completed 2, Terminated 1 |
Follow rofecoxib: new trials by email Literature Review of rofecoxib trials Research Report on rofecoxib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Coxib-inhibition of Duodenal Polyp Growth in FAP Rofecoxib, placebo - Duodenal Polyposis | Phase 2 / Phase 3 | Terminated | Oslo University Hospital | 38 | 2003-09-01 | 2011-07-06 |
| Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC gemcitabine, prolonged continuous infusion gemcitabine, cisplatin - Advanced Non-small Cell Lung Cancer | Phase 2 / Phase 3 | Completed | National Cancer Institute, Naples | 400 | 2003-01-01 | 2023-03-23 |
| Rofecoxib and Bupivacaine to Prevent Pain After Third Molar (Wisdom Tooth) Extraction Rofecoxib and Bupivacaine - Pain, Tooth Extraction | Phase 2 | Completed | National Institute of Dental and Craniofacial Research (NIDCR) | 136 | 2002-12-01 | 2008-03-04 |
| Rofecoxib to Prevent Pain After Third Molar (Wisdom Tooth) Extraction Rofecoxib - Pain | Phase 2 | Completed | National Institute of Dental and Craniofacial Research (NIDCR) | 150 | 2001-11-01 | 2008-03-04 |
| A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study) Rofecoxib, Naproxen - Alzheimer Disease | Phase 2 / Phase 3 | Completed | National Institute on Aging (NIA) | 2009-12-11 |
Hyperalgesia (2) · Pain (2) · Alzheimer Disease (1)
National Institute of Dental and Craniofacial Research (NIDCR) (2) · National Cancer Institute, Naples (1) · National Institute on Aging (NIA) (1) · Oslo University Hospital (1)
United States (3) · Italy (1) · Norway (1)
Cesare Gridelli, M.D. (1) · Francesco Perrone, M.D., Ph.D. (1) · Leon Thal, MD (1)